Current status and new developments in ion therapy

Strahlentherapie und Onkologie

Volumn 183, Issue 6, 2007, Pages 295-300

  Karger, Christian P ^a   Jäkel, Oliver ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Heavy charged particles; Heavy ions; Protons; Radiotherapy

Indexed keywords

ARTICLE; BEAM THERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; ION THERAPY; PARTICLE SIZE; RADIATION DOSE DISTRIBUTION; TREATMENT PLANNING;

EQUIPMENT DESIGN; HEAVY IONS; NEOPLASMS; PROTONS; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, CONFORMAL; RELATIVE BIOLOGICAL EFFECTIVENESS; SCATTERING, RADIATION;

EID: 34347268050     PISSN: 01797158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00066-007-1645-x     Document Type: Article

References (58)

1. Amaldi U. CNAO - the Italian Centre for Light-Ion Therapy. Radiother Oncol 2004;73:Suppl 2:S191-201.
2. Blattmann H. Beam delivery systems for charged particles. Radiat Environ Biophys 1992;31:219-31.
3. Brahme A. Recent advances in light ion radiation therapy. Int J Radiat Oncol Biol Phys 2004;58:603-16.
4. Castro JR. Results of heavy ion radiotherapy. Radiat Environ Biophys 1995;34:45-8.
5. Castro JR, Linstadt DE, Bahary JP, et al. Experience in charged particle irradiation of tumors of the skull base: 1977-1992. Int J Radiat Oncol Biol Phys 1994;29:647-55.
6. Castro JR, Petti PL, Daftari IK, et al. Clinical gain from improved beam delivery systems. Radiat Environ Biophys 1992;31:233-40.
7. Grosu AL, Piert M, Weber WA, et al. Positron emission tomography for radiation treatment planning. Strahlenther Onkol 2005;181:483-99.
8. Grötzinger SO, Li Q, Rietzel E, et al. 3D online compensation of target motion with scanned particle beam. Radiother Oncol 2004;73:Suppl 2:S77-9.
9. Haberer T, Becher W, Schardt D, et al. Magnetic scanning system for heavy ion therapy. Nucl Instrum Meth 1993;A330:296-305.
10. Haberer T, Debus J, Eickhoff H, et al. The Heidelberg Ion Therapy Center. Radiother Oncol 2004;73:Suppl 2:S186-90.
11. Hata M, Tokuuye K, Sugahara S, et al. Proton beam therapy for hepatocellular carcinoma patients with severe cirrhosis. Strahlenther Onkol 2006;182:713-20.
12. Heeg P, Eickhoff H, Haberer T. [Conception of heavy ion beam therapy at Heidelberg University (HICAT).] Z Med Phys 2004;14:17-24.
13. Hug EB, Slater JD. Proton radiation therapy for chordomas and chondrosarcomas of the skull base. Neurosurg Clin N Am 2000;11:627-38.
14. Jäkel O. Ranges of ions in metals for use in particle treatment planning. Phys Med Biol 2006;51:N173-7.
15. Jäkel O, Jacob C, Schardt D, et al. Relation between carbon ion ranges and x-ray CT numbers. Med Phys 2001;28:701-3.
16. Jäkel O, Krämer M, Karger CP, et al. Treatment planning for heavy ion radiotherapy: clinical implementation and application. Phys Med Biol 2001;46:1101-16.
17. Jäkel O, Krämer M, Schulz-Ertner D, et al. Treatment planning for carbon ion radiotherapy in Germany: review of clinical trials and treatment planning studies. Radiother Oncol 2004;73:Suppl 2:S86-91.
18. Jäkel O, Reiss P. The influence of metal artefacts on the range of ion beams. Phys Med Biol 2007;52:635-44.
19. Jäkel O, Schulz-Ertner D, Karger CP, et al. Heavy ion therapy: status and perspectives. Technol Cancer Res Treat 2003;2:377-87.
20. Kanai T, Endo M, Minohara S, et al. Biophysical characteristics of HIMAC clinical irradiation system for heavy-ion radiation therapy. Int J Radiat Oncol Biol Phys 1999;44:201-10.
21. Kanai T, Furusawa Y, Fukutsu K, et al. Irradiation of mixed beam and design of spread-out Bragg peak for heavy-ion radiotherapy. Radiat Res 1997;147:78-85.
22. Kanematsu N, Matsufuji N, Kohno R, et al. A CT calibration method based on the polybinary tissue model for radiotherapy treatment planning. Phys Med Biol 2003;48:1053-64.
23. Karger CP, Peschke P, Sanchez-Brandelik R, et al. Radiation tolerance of the rat spinal cord after 6 and 18 fractions of photons and carbon ions: experimental results and clinical implications. Int J Radiat Oncol Biol Phys 2006;66:1488-97.
24. Kraft G. Tumor therapy with heavy charged particles. Prog Part Nucl Phys 2000;45(Suppl):S473-544.
25. Kraft G. Tumor therapy with ion beams. Nucl Instrum Meth 2000;A454:1-10.
26. Krämer M, Jäkel O, Haberer T, et al. Treatment planning for heavy-ion radiotherapy: physical beam model and dose optimization. Phys Med Biol 2000; 45:3299-317.
27. Krämer M, Scholz M. Treatment planning for heavy-ion radiotherapy: calculation and optimization of biologically effective dose. Phys Med Biol 2000; 45:3319-30.
28. Krämer M, Scholz M. Rapid calculation of biological effects in ion radiotherapy. Phys Med Biol 2006;51:1959-70.
29. Li Q, Groezinger SO, Haberer T, et al. Online compensation for target motion with scanned particle beams: simulation environment. Phys Med Biol 2004;49:3029-46.
30. Lomax AJ, Boehringer T, Coray A, et al. Intensity modulated proton therapy: a clinical example. Med Phys 2001;28:317-24.
31. Minohara S, Endo M, Kanai T, et al. Estimating uncertainties of the geometrical range of particle radiotherapy during respiration. Int J Radiat Oncol Biol Phys 2003;56:121-5.
32. Minohara S, Kanai T, Endo M, et al. Respiratory gated irradiation system for heavy-ion radiotherapy. Int J Radiat Oncol Biol Phys 2000;47:1097-103.
33. Mock U, Bogner J, Georg D, et al. Comparative treatment planning on localized prostate carcinoma. Conformal photon- versus proton-based radiotherapy. Strahlenther Onkol 2005;181:448-55.
34. Munzenrider JE, Liebsch NJ. Proton therapy for tumors of the skull base. Strahlenther Onkol 1999;175:Suppl 2:57-63.
35. Nill S, Bortfeld T, Oelfke U. Inverse planning of intensity modulated proton therapy. Z Med Phys 2004;14:35-40.
36. Noel G, Habrand JL, Jauffret E, et al. Radiation therapy for chordoma and chondrosarcoma of the skull base and the cervical spine. Prognostic factors and patterns of failure. Strahlenther Onkol 2003;179:241-8.
37. Paganetti H. Significance and implementation of RBE variations in proton beam therapy. Technol Cancer Res Treat 2003;2:413-26.
38. Paganetti H, Niemierko A, Ancukiewicz M, et al. Relative biological effectiveness (RBE) values for proton beam therapy. Int J Radiat Oncol Biol Phys 2002;53:407-21.
39. Pedroni E, Bacher R, Blattmann H, et al. The 200-MeV proton therapy project at the Paul Scherrer Institute: conceptual design and practical realization. Med Phys 1995;22:37-53.
40. Pedroni E, Bohringer T, Coray A, et al. Initial experience of using an active beam delivery technique at PSI. Strahlenther Onkol 1999;175:Suppl 2: 18-20.
41. Pedroni E, Scheib S, Bohringer T, et al. Experimental characterization and physical modelling of the dose distribution of scanned proton pencil beams. Phys Med Biol 2005;50:541-61.
42. Rietzel E, Rosenthal SJ, Gierga DP, et al. Moving targets: detection and tracking of internal organ motion for treatment planning and patient set-up. Radiother Oncol 2004;73:Suppl 2:S68-72.
43. Schneider U, Pedroni E, Lomax A. The calibration of CT Hounsfield units for radiotherapy treatment planning. Phys Med Biol 1996;41:111-24.
44. Scholz M, Kellerer AM, Kraft-Weyrather W, et al. Computation of cell survival in heavy ion beams for therapy. The model and its approximation. Radiat Environ Biophys 1997;36:59-66.
45. Schulz-Ertner D, Jäkel O, Schlegel W. Radiation therapy with charged particles. Semin Radiat Oncol 2006;16:249-59.
46. Schulz-Ertner D, Karger CP, Feuerhake A, et al. Effectiveness of carbon ion radiotherapy in the treatment of skull base chordomas. Int J Radiat Oncol Biol Phys 2007;68:449-57.
47. Schulz-Ertner D, Nikoghosyan A, Didinger B, et al. Carbon ion radiation therapy for chordomas and low grade chondrosarcomas - current status of the clinical trials at GSI. Radiother Oncol 2004;73:Suppl 2:S53-6.
48. Schulz-Ertner D, Nikoghosyan A, Didinger B, et al. Therapy strategies for locally advanced adenoid cystic carcinomas using modern radiation therapy techniques. Cancer 2005;104:338-44.
49. Schulz-Ertner D, Nikoghosyan A, Hof H, et al. Carbon ion radiotherapy of skull base chondrosarcomas. Int J Radiat Oncol Biol Phys 2007;67:171-7.
50. Sisterson J, ed. Particle Newsletter 36. Boston: Harvard Cyclotron Laboratory, Harvard University, 2005 (www.ptcog.com).
51. Suit H. The Gray Lecture 2001: Coming technical advances in radiation oncology. Int J Radiat Oncol Biol Phys 2002;53:798-809.
52. Timmermann B, Schuck A, Niggli F, et al. ["Spot-scanning" proton therapy for rhabdomyosarcomas of early childhood. First experiences at PSI.] Strahlenther Onkol 2006;182:653-9.
53. Tokuuye K, Akine Y, Kagei K, et al. Proton therapy for head and neck malignancies at Tsukuba. Strahlenther Onkol 2004;180:96-101.
54. Tsuji H, Yanagi T, Ishikawa H, et al. Hypofractionated radiotherapy with carbon ion beams for prostate cancer. Int J Radiat Oncol Biol Phys 2005;63:1153-60.
55. Tsujii H, Mizoe JE, Kamada T, et al. Overview of clinical experiences on carbon ion radiotherapy at NIRS. Radiother Oncol 2004;73:Suppl 2:S41-9.
56. Weber DC, Rutz HP, Pedroni ES, et al. Results of spot-scanning proton radiation therapy for chordoma and chondrosarcoma of the skull base: the Paul Scherrer Institut experience. Int J Radiat Oncol Biol Phys 2005;63:401-9.
57. Wertz H, Jäkel O. Influence of iodine contrast agent on the range of ion beams for radiotherapy. Med Phys 2004;31:767-73.
58. Zips D, Adam M, Flentje M, et al. Impact of hypoxia and the metabolic microenvironment on radiotherapy of solid tumors. Introduction of a multiinstitutional research project. Strahlenther Onkol 2004;180:609-15.